This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With Novo Nordisk, Eli Lilly and AstraZeneca leading the way, Big Pharma's sales will grow 4% annually through 2030: analysts kdunleavy Mon, 10/02/2023 - 15:19
At the beginning of each year, we compile our sales hiring forecast by looking at the overall hiring forecasts for the year made by Manpower, Glassdoor, Indeed, Monster, and the Bureau of Labor & Statistics (BLS). 2021 Sales Hiring in Review. 2021 Sales Hiring in Review. 2022 Sales Forecast for Hiring.
The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% The figure below summarises the endometriosis market growth across the 7MM from 2020 to 2030. At the end of 2030, the US will contribute approximately 81.3% of 7MM sales.
Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%
GlobalData predicts Bristol-Myers Squibb’s Breyanzi and Gilead’s Yescarta are set to have high annual sales in the forecast period. Yescarta for blood cancer Yescarta is targeting expansions into the first line for diffuse large B-cell lymphoma (DLBCL) and second line for follicular lymphoma in 2030. billion in 2031.
billion by 2030 The post France gets new sterile liquid drug manufacturing facility appeared first on European Pharmaceutical Review. The 9,500m 2 facility will harness state-of-the-art containment technologies, Baduel confirmed. HPAPI contract manufacturing to value $14.6
Without a successful sales team , an organization can’t thrive. The sales team turns leads into customers, guiding prospects through their concerns until they arrive at the sale. That leads to another question: how do you identify and hire the best sales manager for your organization?
India’s Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss. The $11.50 The report predicts that the alopecia areata market will grow to as much as $2.5
You need to optimize your company’s solar sales funnel. Of course, wanting to improve your solar sales process and actually doing it are different things. Understanding Solar Sales Before we discuss the various stages of the solar sales funnel, let’s zoom out and analyze the industry as a whole.
Furthermore, the organization predicts it will outpace the GDP by 2030. This is great news for those in medtech sales! And your reps need to adopt an omnichannel process that uses all of the medical device sales channels at their disposal. Each threatens to derail your medical device sales process in some way.
Most seasoned medical sales representatives have carried several different products or services over their careers. Between emerging technologies, expiring patents, and ever-changing insurance coverage, the role of a medical sales professional is to constantly adapt and learn new things. Gives you an area of expertise.
UniQure announced that it had received $100m from this first commercial sale milestone, on top of a $450m upfront payment. It is eligible for up to $1.6bn based on future milestones, as well as royalties amounting to more than 20% of net product sales. Haemophilia B is a rare condition.
Based on their rising popularity to treat type 2 diabetes and obesity, GlobalData has predicted that sales of glucagon-like peptide-1 receptor (GLP-1R) drugs will increase fourfold to an estimated $142 billion by 2030. 1 Considering the 11 approved GLP-1R drugs “generated $37.2 1 Considering the 11 approved GLP-1R drugs “generated $37.2
Merck would not be the first company to do so, Gilead was prepared to pay $21 billion for Immunomedics and thereby add Trodelvy (sacituzumab govitecan) to its portfolio, as part of the company’s plans to generate one-third of its revenues from cancer drugs in 2030. Looking to the future. billion in revenue last year.
This next extension beyond 2030 is a testament to the success and trust of the partnership, as well as to the high degree of confidence placed in our platforms and the complementary approach to generating a leading pipeline of highly innovative drug candidates.
“Novo Nordisk is proud to lead the industry in sustainable business practices, doing our part to give empty pens new purpose,” said the company’s UK general manager, Pinder Sahota. Novo Nordisk is also working towards zero CO2 emissions from operations and transportation by 2030.
billion in 2030 ). A buyer persona is a semi-fictional representation of your ideal customer based on sales data and industry research. Analyzing your data and creating buyer personas to support your data will help you better understand your target audience, increase leads, and improve your inbound medical device marketing strategy.
It is also being developed for use in pregnant women to prevent RSV in newborns, an indication for which it looks to be in the lead after GSK was forced to halt three clinical trials while it investigates a safety signal. For children younger than five years old in the US, the infection leads to approximately 2.1
It follows that healthcare providers should be motivated to reduce their carbon footprint, and they are: 20 country health systems have pledged to achieve net zero, with target dates between 2030 and 2050, including the UK, Spain, Norway, and Belgium. She holds a degree in biochemistry from Oxford University.
from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. from 2023 to 2030. Poised to grow at a CAGR of 29.4% billion in 2022 and will expand at a CAGR of 10.3%
BioNTech is anticipated to lead the market with a predicted $885 million in sales, and a 44.6 billion by 2030 BioNTech Development of mRNA-based oncology therapies for German biotech BioNTech is progressing. OTX-2002 from Omega Therapeutics is an mRNA therapy anticipated to generate $658 million in global sales, representing 33.2
is a diverse country and different communities may have different needs, a key gap in most organizations is they don’t understand what truly drives sales through a dedicated multicultural marketing investment. In fact, in many cases, the data and insights that drive sales are the opposite of what people think.
Bayer has promised gender parity at all management levels by 2030, so white women are in the pole position. Leading the media team, I can assure you our engagement with these communities mirrored the company’s engagement with us as employees. There is an over index for Asian and white people and very few LatinX and Black people.
Worldwide, RSV infections lead to more than three million hospitalisations and almost 60,000 deaths in children under five years of age every year, with around half of fatalities in infants less than six months. AZ and Sanofi say they hope to launch the antibody next autumn, in time for the 2023/24 RSV season.
The former blockbuster – first approved back in 1998 – is still making solid sales despite losing patent protection, with AZ booking $410 million from the drug last year, but are expected to drop sharply once Beyfortus and vaccines for RSV prevention reach the market.
holds the largest share of the medical device market, accounting for over 40% of global sales. Heres why a strong SEO strategy is essential: Boosted Lead Generation: MedTech companies leveraging SEO can generate up to 50% more leads than those without an optimized search presence. Moreover, the U.S. close rate.
With analysts estimating that obesity drug sales could top $100 billion annually , concerns over the financial hit is likely why plans covering 30% of lives do not reimburse Wegovy, per Clarivate Fingertip Analytics data. The arrival of a second drug may drive PBMs to expand coverage in exchange for aggressive rebates.
Prioritize Education Over Sales Older adults and seniors prefer unbiased education over high-pressure sales tactics to make informed decisions. In fact, some expectations will be 60% penetration by 2030, which is just five years away. direct mail, TV, digital, and email) to reach older, tech-savvy generations.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content